iCAD (ICAD) Sells Xoft

Go back to iCAD (ICAD) Sells Xoft

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

October 23, 2023 8:01 AM UTC

NASHUA, N.H., Oct. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions announced today that Elekta (EKTA-B.ST), the world leader in brachytherapy solutions, has agreed to acquire Xoft, a subsidiary of iCAD, Inc. for approximately $5.5 million and assumed liabilities. Elekta is taking over the business effective immediately and will make final payment no later... More